A. Gilles, B. Pharmacie-clinique-alain, B. Jean-claude, C. Santé-publique-christine, F. Pharmacologie-cardiovasculaire-chantal et al., Chimie physique générale, Biologie cellulaire oncologique Jean-Bernard REGNOUF de VAINS ........Chimie thérapeutique Bertrand RIHN ..................................Biochimie, Biologie

A. Monique, V. Bactériologie, B. Sandrine, B. Mariette, B. Biologie-cellulaire-emmanuelle et al., Chimie thérapeutique François BONNEAUXChimie thérapeutique

B. Ariane, B. Cédric, C. Jean-claude, C. Chimie-générale-et-minérale-igor, C. Chimie-analytique-jocelyne et al., Toxicologie, Microbiologie clinique Béatrice FAIVRE ................................Hématologie Adel FAIZ..........................................Biophysique

H. Thierry, J. Chimie-organique-frédéric, . Santé, J. Olivier, . Toxicologie et al., Biophysique, Informatique Christine PERDICAKIS ........................Chimie

S. Anne, S. Pharmacie-galénique-marie-paule, B. Mycologie, T. Nathalie, T. Santé-publique-gabriel et al., Pharmacie galénique PROFESSEUR ASSOCIE, Biochimie et Biologie moléculaire Colette ZINUTTI

C. Christophe, Anglais ASSISTANT

M. Matériel, 45 3.1. Chromatographie Liquide Haute Performance (HPLC) phase inverse : (Dosage de la teneur en Para-aminophénol), p.48

.. Discussion-conclusion, 71 1. arome orange+benzoate de sodium 2. arome orange + saccharine 3. arome orange + saccharose 4. arome orange + paracétamol 5. benzoate de sodium + saccharine 6. benzoate de sodium + saccharose 7. benzoate de sodium + paracétamol 8. saccharine + saccharose 9. saccharine + paracétamol 10. saccharose + paracétamol b. Tests ternaires : 1. arome orange-benzoate de sodium-saccharine 2. arome orange-benzoate de sodium-saccharose 3. arome orange-benzoate de sodium ?paracétamol 4. arome orange-saccharine-saccharose 5. arome orange-saccharine-paracétamol 6. arome orange-saccharose ?paracétamol 7. benzoate de sodium ?saccharine-saccharose 8. benzoate de sodium ?saccharine-paracétamol 9

T. Antoine, Suivi de lancement d'un nouvel antalgique de palier 2 : association fixe de Paracétamol-Tramadol. Th : Docteur en pharmacie, Faculté de medecine et de pharmacie Besançon, pp.25-30, 2005.

J. E. Fairbrother and . Acetaminophen, Analytical Profiles of Drug Substances, pp.1-109, 1974.

K. T. Koshy and J. L. Lach, Stability of Aqueous Solutions of N-Acetyl-p-aminophenol, Journal of Pharmaceutical Sciences, vol.50, issue.2, pp.113-118, 1961.
DOI : 10.1002/jps.2600500204

Q. G. Fogg and A. M. Summan, Stabilisation by éthylènediamine tétraacetic acid of amid and other groups in drug compound, J. Clin. Pharm. Ther, pp.17-107, 1992.

D. Dahlin and N. S. , Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen, J. Med. Chem, pp.25-885, 1982.

R. C. Heading, J. Nimmo, L. F. Prescott, and P. Tothill, The dependence of paracetamol absorption on the rate of gastring emptying, Br. J. Pharmacol, pp.47-415, 1973.

W. E. Bengall, J. Kelleher, B. E. Walker, and M. S. Losowsky, The gastrointestinal absorption of paracetamol in the rat, J. Pharm. Pharmacol, pp.31-157, 1979.

P. M. Hammond, M. D. Scawen, and C. P. Paice, ENZYME BASED PARACETAMOL ESTIMATION, The Lancet, vol.317, issue.8216, pp.391-392, 1981.
DOI : 10.1016/S0140-6736(81)91717-7

J. P. Glynn and S. E. Kendal, PARACETAMOL MEASUREMENT, The Lancet, vol.305, issue.7916, pp.1147-1148, 1975.
DOI : 10.1016/S0140-6736(75)92542-8

W. L. Chiou, Estimation of Hepatic First-Pass Effect of Acetaminophen in Humans after Oral Administration, Journal of Pharmaceutical Sciences, vol.64, issue.10, pp.1734-1735, 1975.
DOI : 10.1002/jps.2600641044

W. S. Nimmo, R. C. Heading, J. Wilson, P. Tothill, and L. F. Prescott, Inhibition of gastric emptying and drug absorption by narcotic analgesics., British Journal of Clinical Pharmacology, vol.4, issue.6
DOI : 10.1136/bmj.4.5939.265

A. Lavarenne, Paracetamol et phénacétine: pharmacologie Clinique

M. Gilveray, I. J. Mattok, and G. L. , Some factors affecting the absorption of paracetamol, J. Pharm. Pharmacol, pp.615-619, 1972.

W. S. Nimmo and L. F. Prescott, THE INFLUENCE OF POSTURE ON PARACETAMOL ABSORPTION, British Journal of Clinical Pharmacology, vol.50, issue.4, pp.348-354, 1978.
DOI : 10.1136/adc.50.7.500

D. Marcia, D. J. Greenblatt, and A. D. Rabernethy, Effect of food on acetaminophen absorption in young and elderly subjects, J. Clin. Pharmacol, pp.22-571, 1982.

P. Bajorek, B. Widdop, and G. Volans, LACK OF INHIBITION OF PARACETAMOL ABSORPTION BY CODEINE, British Journal of Clinical Pharmacology, vol.23, issue.4, pp.346-347, 1978.
DOI : 10.1111/j.2042-7158.1971.tb08613.x

B. Bannwarth and F. Pehourcq, Bases pharmacologiques de l'emploi du paracetamol : aspects pharmacocinétiques et pharmacodynamiques

M. D. Rawlins, D. B. Henderson, and A. R. Hijab, Paharmacokinetics of acetaminophen after intravenous and oral administration, Eur. J. Clin. Pharmacol, issue.11, pp.283-286, 1977.

J. M. Cardot, J. M. Aiache, R. Renoux, and J. P. Kantelip, Correlation entre les taux salivaires et les taux plasmatiques de paracetamol ; interet pour les études de biodisponibilité, S.T.P. Pharm, vol.1, issue.2, pp.114-120, 1985.

B. G. Gazzard, A. W. Ford-hutchinson, M. J. Smith, and S. R. William, The binding of paracetamol to plasma proteins of man and pig, Journal of Pharmacy and Pharmacology, vol.2, issue.12, pp.25-964, 1973.
DOI : 10.1016/S0140-6736(73)90470-4

L. F. Prescott, Kinetics and matabolismm of paracetamol and phenacetin

D. M. Aronoff, J. A. Oates, and O. Boutaud, New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases, Clinical Pharmacology & Therapeutics, vol.79, issue.1
DOI : 10.1016/j.clpt.2005.09.009

R. P. Miller, R. J. Roberts, and L. J. Fischer, Acetaminophen elimination kinetics in neonates, children, and adults, Clinical Pharmacology & Therapeutics, vol.19, issue.3, pp.284-294, 1976.
DOI : 10.1002/cpt1976193284

G. G. Graham and K. F. Scott, Mechanism of Action of Paracetamol, American Journal of Therapeutics, vol.12, issue.1
DOI : 10.1097/00045391-200501000-00008

G. Keck, Toxicité et effets indésirables des antiinflamatoires non stéroidiens Etude des cas rapportés au CNITV, Rec. Med. Vét. Spéciale antiinflamatoires, issue.57, pp.168-615, 1992.

V. Poletti, Les intoxications medicamenteuses aigues chez les carnivores domestiques : presentation des données épidemiologiques du CNITV d'Alfort et analyse des intoxications les plus frequentes, Th : Vet : ENVA, 1996.

T. R. Knight, M. W. Fariss, A. Farhood, and H. Jaeschke, Role of Lipid Peroxidation as a Mechanism of Liver Injury after Acetaminophen Overdose in Mice, Toxicological Sciences, vol.76, issue.1, pp.229-236, 2003.
DOI : 10.1093/toxsci/kfg220

K. Brandt, Paracetamol in the Treatment of Osteoarthritis Pain, Drugs, vol.39, issue.Special Issue 2, pp.23-41, 2003.
DOI : 10.2165/00003495-200363992-00005

N. A. Buckley, I. M. Whyte, D. L. O-'connell, and A. H. Dawson, Oral or intravenous N-acetylcysteine : which is the treatment of choice for acetaminophen (paracetamol) poisoning, J. Toxicol. Clin. Toxicol, issue.6, pp.37-759, 1999.

H. Dong, R. L. Haining, K. E. Thummel, A. E. Rettie, and S. D. Nelson, Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen, Drug Metab. Dispos, issue.12, pp.28-1397, 2000.

J. A. Clements, J. A. Critchley, and L. F. Prescott, The effect of dose on the pharmacokinetics and absolute biovailability of oral paracetamol, J

C. J. Montgomery, J. P. Mc-cormack, C. C. Reichert, and C. P. Marsland, Plasma concentrations after high-dose (45 mg.kg-1) rectal acetaminophen in children, Can. J. Anaesth, issue.11, pp.42-982, 1995.

L. F. Prescott, Nouvelles perspectives avec le paracétamol, Drugs, vol.63, issue.2, pp.51-56, 2003.

M. E. Moris and G. Levy, Renal Clearance and Serum Protein Binding of Acetaminophen and Its Major Conjugates in Humans, Journal of Pharmaceutical Sciences, vol.73, issue.8, pp.73-1038, 1984.
DOI : 10.1002/jps.2600730806

F. Ellis, Paracetamol: a curriculum resource, 2002.

A. J. Cummings, M. L. King, and B. K. Martin, A KINETIC STUDY OF DRUG ELIMINATION: THE EXCRETION OF PARACETAMOL AND ITS METABOLITES IN MANMETABOLITES IN MAN, British Journal of Pharmacology and Chemotherapy, vol.44, issue.2
DOI : 10.1042/bj0440239

J. Bonnefont, J. P. Courade, A. Allaoui, and A. Eschalier, Mechanism of the Antinociceptive Effect of Paracetamol*, Drugs, vol.92, issue.Special Issue 2, pp.1-4, 2003.
DOI : 10.2165/00003495-200363992-00002

B. B. Brodie and J. Axelrod, The fate of acetanilide in man, J. Pharmacol

F. B. Flinn and B. B. Brodie, The effect on the pain threshold of N -acetyl p aminophenol , a product derived in the body from acetanilide, J

R. J. Flower and J. R. Vane, Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol), Nature, vol.7, issue.5381
DOI : 10.1111/j.1476-5381.1957.tb00146.x

L. J. Roberts and J. D. Marrow, Analgesic-antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout

N. V. Chandrasekharan, H. Dai, T. Ross, L. K. Evanson, N. K. Tomsik et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proceedings of the National Academy of Sciences, vol.96, issue.6, pp.99-13926, 2002.
DOI : 10.1073/pnas.96.6.3275

B. Kis, J. A. Snipes, and D. W. Busija, Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties, Journal of Pharmacology and Experimental Therapeutics, vol.315, issue.1
DOI : 10.1124/jpet.105.085431

K. Henney and B. Dudley, Handbook of Photography . Whittlesey House, p.324, 1939.

K. R. Ing, Y a-t-il un rationnel à combiner le paracétamol et un AINS

T. D. Warner and J. A. Mitchell, Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic, The FASEB Journal, vol.18, issue.7, pp.780-804, 2004.
DOI : 10.1073/pnas.96.13.7563

C. Remy, E. Marret, and F. Bonnet, Évaluation et traitement de la douleur, pp.639-648, 2006.

J. A. Mitchell, P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane, Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase., Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.90-11693, 1993.
DOI : 10.1073/pnas.90.24.11693

A. Roca-vinardell, A. Ortega-alvaro, J. Gibert-rahola, and J. Micó, The Role of 5-HT1A/B Autoreceptors in the Antinociceptive Effect of Systemic Administration of Acetaminophen, Anesthesiology, vol.98, issue.3, pp.98-741, 2003.
DOI : 10.1097/00000542-200303000-00025

J. Bonnefont, A. Alloui, and E. Chapuy, Orally Administered Paracetamol Does Not Act Locally in the Rat Formalin Test, Anesthesiology, vol.99, issue.4, pp.99-976, 2003.
DOI : 10.1097/00000542-200310000-00034

A. Tjolsen, A. Lund, and K. Hole, Antinociceptive effect of paracetamol in rats is partly dependent of spinal serotoninergic systems, Eur. J. Pharmacol, pp.193-201, 0193.

G. G. Graham, K. F. Scott, and . Amer, Mechanism of Action of Paracetamol, American Journal of Therapeutics, vol.12, issue.1
DOI : 10.1097/00045391-200501000-00008

P. J. Harvison, R. W. Egan, P. H. Gale, and S. D. Nelson, Acetaminophen as a Cosubstrate and Inhibitor of Prostaglandin H Synthase
DOI : 10.1007/978-1-4684-5134-4_68

S. Ohki, N. Ogino, S. Yamamoto, and O. Hayaishi, Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes, J. Biol. Biol. Chem, vol.254, issue.3, pp.829-836, 1979.

A. S. Travis, Manufacture and uses of the anilines: A vast array of processes and products. Zvi Rappoport. The chemistry of Anilines Wiley, p.764, 2007.

L. F. Prescott, Nouvelles perspectives avec le paracétamol, Drugs, vol.63, issue.2, pp.51-56, 2003.

G. F. Merrill, Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms, American Journal of Physiology-Heart and Circulatory Physiology, vol.254, issue.4, pp.1341-1349, 2002.
DOI : 10.1016/S0008-6363(96)00254-4

URL : http://ajpheart.physiology.org/content/ajpheart/282/4/H1341.full.pdf

L. F. Prescott, Paracetamol, American Journal of Therapeutics, vol.7, issue.2, pp.143-147, 2000.
DOI : 10.1097/00045391-200007020-00011

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2125.2000.00167.x/pdf

P. Skelbred, B. Album, and P. Lokken, Acetylsalicylic acid vs paracetamol: Effects on post-operative course, European Journal of Clinical Pharmacology, vol.I, issue.4, pp.12-257, 1977.
DOI : 10.1007/BF00607424

H. Raybaud, Fièvre de l'enfant et du nourrisson

F. Schneider, M. Hasselmann, and C. Kummerlen, Le paracétamol : produit analgésique, antipyrétique sans action anti-inflammatoire. La revue du praticien-Médecine générale, pp.54-63, 1989.

L. F. Prescott, Paracetamol, alcohol and the liver, British Journal of Clinical Pharmacology, vol.62, issue.Suppl. 5A, pp.291-301, 2000.
DOI : 10.1016/S0009-9236(97)90148-X

R. C. Dart and E. Bailey, Does Therapeutic Use of Acetaminophen Cause Acute Liver Failure?, Pharmacotherapy, vol.19, issue.9, pp.1219-1230, 2007.
DOI : 10.1016/0002-9343(83)90444-8

J. Lawrence, Paracetamol as a risk factor for allergic disorders. The Lancet, pp.119-121, 2009.

O. Moling, E. Cairon, G. Rimenti, F. Rizza, R. Pristerá et al., Severe hepatotoxicity after therapeutic doses of acetaminophen, Clinical Therapeutics, vol.28, issue.5, pp.28-755, 2006.
DOI : 10.1016/j.clinthera.2006.05.002

F. F. Daly, J. S. Fountain, L. Murray, A. Graudins, and N. A. Buckley, Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres, Med. J. Aust, pp.188-296, 2008.

G. G. Geaham, R. I. Graham, and R. O. Day, Comparative analgesia, cardiovascular and renal effects of celecoxib. Rofecoxib and acetaminophen (paracetamol), Curr. Pharm. Des, issue.8, pp.1063-1075, 2002.

A. Flaks and B. Flaks, Induction of liver cell tumors in 1 F mice by paracetamol, Carcinogenesis, issue.4, pp.363-368, 1983.

A. Flaks, B. Flaks, and A. P. Shaw, Induction by paracetamol of bladder and liver tumors in the rat, Acta. Pathol. Microbio. Immunol. Scand. Section A, pp.93-376, 1985.

R. Hasegawa, F. Furukawa, and K. Toyoda, Studie for tumor initiating effect of acetaminophen in two stage liver carcinogenesis of male F 344 rats

G. D. Freidman and G. K. Ury, Initial sceening for carcinogenicity of commonly used drugs, J. natl. cancer instit, pp.65-723, 1980.

B. Laboratoire, Doliprane : tératogénése, fonctions de reproduction mutagénése. Nanterre : Division synthemedica, 1982.

P. Lechat and R. Kisch, Le paracetamol : actualisation des données en 1989, Therapie, vol.44, pp.337-354, 1989.

A. C. Bronstein and B. H. Rumack, Acute acetaminophen overdose during pregnancy : review of fifty nine cases. annual scientific meeting, 1984.

W. Shen, L. M. Kamendulis, S. D. Ray, and G. B. Corcoran, Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: Correlation of nuclear Ca2+ accumulation and early DNA fragmentation with cell death, Toxicology and Applied Pharmacology, vol.111, issue.2, pp.242-254, 1992.
DOI : 10.1016/0041-008X(91)90028-D

B. H. Lubek, M. Avaria, P. Basu, and P. G. Wells, Pharmacological studies on the in vitro cataractogenocity of acetaminophen in mice and rabbits

G. V. Dussarat, J. Dalger, B. Mafart, and A. Chagnon, Prupura vasculaire au paracetamol : une observation, La presse médicale, pp.1587-1592, 1988.

F. Lemoigne, Toxicité et effets indésirables du paracetamol à doses thérapeutiques et sub-thérapeutiques, Th : Doctorat en pharmacie, U.E.R. des sciences médicales et pharmaceutiques, pp.163-173, 1992.

. Journal-officiel-de-la-république-française, Décrets, arrêtés, circulaires, textes généraux, ministère des solidarités, de la santé et de la famille, Arrêté du 7 mars 2005 portant application de l'article R. 5121-41-2 du code de la santé publique et relatif aux modifications des autorisations de mises sur le marché, 2005.